Dual inhibition of PI3K and PARP demonstrates synergistic anti-tumor activity in endometrioid endometrial cancer patient derived xenografts

被引：0
|
作者：
Hall, Tracilyn [1 ]
DiGloria, Celeste [1 ]
Kim, Minji [1 ]
Zhang, Ling [1 ]
Foster, Rosemary [1 ]
Growdon, Whitfield [1 ]
Rueda, Bo [1 ]
机构：
[1] Harvard Univ, Massachusetts Gen Hosp, Cambridge, MA 02138 USA
来源：
GYNECOLOGIC ONCOLOGY | 2015年 / 136卷 / 02期
关键词：
D O I：
10.1016/j.ygyno.2014.11.033
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：398 / 398
页数：1
相关论文
共 50 条
  • [31] Anti-tumor Efficacy Profile of a Novel Dual PI3K/mTOR Inhibitor, DS-7423
    Hirota, Y.
    Sato, K.
    Hama, Y.
    Nagashima, Y.
    Watanabe, R.
    Suzuki, N.
    Sugimura, M.
    Shiose, Y.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 110 - 110
  • [32] Combined PI3K Inhibitor and Eribulin Enhances Anti-Tumor Activity in Preclinical Models of Paclitaxel-Resistant, PIK3CA-Mutated Endometrial Cancer
    Jeong, Yeong Gyu
    Katuwal, Nar Bahadur
    Kang, Min Sil
    Ghosh, Mithun
    Hong, Sa Deok
    Park, Seong Min
    Kim, Seul-Gi
    Kim, Tae Hoen
    Moon, Yong Wha
    CANCERS, 2023, 15 (19)
  • [33] Vertical inhibition of PI3K/Akt/mTOR signaling demonstrates in vitro and in vivo anti-fibrotic activity
    Liang, Minrui
    Lv, Jiaoyan
    Chu, Haiyan
    Wang, Jiucun
    Chen, Xiangjun
    Zhu, Xiaoxia
    Xue, Yu
    Guan, Ming
    Zou, Hejian
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2014, 76 (02) : 104 - 111
  • [34] PI3K/mTOR dual inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A synergistically exert anti-tumor activity in breast cancer
    Chen, Liyan
    Jin, Tiefeng
    Zhu, Kun
    Piao, Yingshi
    Quan, Taihao
    Quan, Chunji
    Lin, Zhenhua
    ONCOTARGET, 2017, 8 (07) : 11937 - 11949
  • [35] Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer
    Solzak, J. P.
    Atale, R.
    Hancock, B.
    Radovich, M.
    CANCER RESEARCH, 2016, 76
  • [36] Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer
    Jeffrey P. Solzak
    Rutuja V. Atale
    Bradley A. Hancock
    Anthony L. Sinn
    Karen E. Pollok
    David R. Jones
    Milan Radovich
    npj Breast Cancer, 3
  • [37] Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer
    Solzak, Jeffrey P.
    Atale, Rutuja V.
    Hancock, Bradley A.
    Sinn, Anthony L.
    Pollok, Karen E.
    Jones, David R.
    Radovich, Milan
    NPJ BREAST CANCER, 2017, 3
  • [38] Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer
    Solzak, J. P.
    Atale, R.
    Hancock, B. A.
    Radovich, M.
    CANCER RESEARCH, 2013, 73
  • [39] Synergistic Anticancer Efficacy of MEK Inhibition and Dual PI3K/mTOR Inhibition in Castration-Resistant Prostate Cancer
    Park, Hongzoo
    Kim, Yunlim
    Sul, Jee-Won
    Jeong, In Gab
    Yi, Hye-Jin
    Ahn, Jae Beom
    Kang, Jong Soon
    Yun, Jieun
    Hwang, Jung Jin
    Kim, Choung-Soo
    PROSTATE, 2015, 75 (15): : 1747 - 1759
  • [40] Similar PI3K and RTK-Ras status in patient derived colorectal cancer-xenografts and patients
    Nunes, Manoel
    Weiswald, Louis-Bastien
    Vrignaud, Patricia
    Vacher, Sophie
    Turlotte, Edouard
    Richon, Sophie
    Bellet, Dominique
    Roman-Roman, Sergio
    Bieche, Ivan
    Dangles-Marie, Virginie
    CANCER RESEARCH, 2013, 73 (08)
12345